1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78207 | Lepzacitinib | JAK | |
Lepzacitinib, a Janus kinase inhibitor, specifically targets JAK 1/3. It demonstrates an anti-inflammatory effect and efficacy in inhibiting atopic dermatitis as well as other skin diseases [1]. |